- Report
- August 2022
- 1834 Pages
Global
From €2377EUR$2,500USD£1,997GBP
- Report
- April 2023
- 350 Pages
Global
From €3508EUR$3,690USD£2,947GBP
Stomach cancer, also known as gastric cancer, is a type of cancer that affects the lining of the stomach. Oncology drugs are used to treat this type of cancer, and the stomach cancer drug market is a subset of the larger oncology drug market. These drugs are used to treat both early and advanced stages of stomach cancer, and can be administered orally, intravenously, or through injections. They can also be used in combination with other treatments such as chemotherapy and radiation therapy.
The stomach cancer drug market is highly competitive, with many companies developing and marketing drugs for the treatment of this type of cancer. Some of the major players in this market include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to improve the treatment of stomach cancer. Show Less Read more